CRBU
NASDAQ
US
Caribou Biosciences, Inc. - Common Stock
$1,94
▼ $-0,05
(-2,51%)
Vol 1.1M
4
Skor Kualitas
fail
Pendapatan ✗
Laba Bersih ✗
>IPO ✗
Kap. Pasar
$148.6M
ROE
-80,8%
Margin
-1690,5%
D/E
0,00
Beta
2,68
52W
$1–$4
Konsensus Wall Street
15 analis · Apr 20265
Beli Kuat
9
Beli
1
Tahan
0
Jual
0
Jual Kuat
93,3%
Peringkat Beli
Grafik Harga
Saham Serupa
ANIK
Anika Therapeutics Inc
$138.6M
SABS
SAB Biotherapeutics Inc
P/E 9,5
$178.0M
ELTX
Elicio Therapeutics Inc
$139.2M
ZNTL
Zentalis Pharmaceuticals Inc
$97.5M
MGNX
MacroGenics Inc
$101.8M
TNXP
Tonix Pharmaceuticals Holding Corp
$199.7M
CRBP
Corbus Pharmaceuticals Holdings Inc
$142.9M
GALT
Galectin Therapeutics Inc
$268.2M
ACHV
Achieve Life Sciences Inc
$264.6M
Pendapatan
Tingkat beat: 75,0%| Kuartal | EPS Estimasi | EPS Aktual | Kejutan |
|---|---|---|---|
| Des 2025 | $-0,32 | $-0,28 | +$0,04 |
| Sep 2025 | $-0,37 | $-0,30 | +$0,07 |
| Jun 2025 | $-0,40 | $-0,58 | $-0,18 |
| Mar 2025 | $-0,45 | $-0,43 | +$0,02 |
Pendapatan & Laba Kuartalan
| Kuartal | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|---|
| Pendapatan | — | $2.1M | $2.4M | $2.7M | $2.2M | $3.9M |
| Laba Bersih | — | -$35.5M | -$40.0M | -$54.1M | -$27.5M | -$26.5M |
Tren Fundamental
| Metrik | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -71.6% | -71.6% | -71.6% | -71.6% | -80.8% | -80.8% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -2028.4% | -1800.9% | -1800.9% | -1800.9% | -1690.5% | -1690.5% |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 6.66 | 6.66 | 6.66 | 6.66 | 5.54 | 5.54 |
Rasio Utama
ROA (TTM)
-62,7%
P/S (TTM)
15,99
P/B
0,6
EPS (TTM)
$-1,70
CF/Share
$-1,36
Pertumbuhan Pendapatan 3T
+1,4%
52W High
$3,54
52W Low
$0,66
$0,66
Rentang 52 Minggu
$3,54
Kesehatan Keuangan
Arus Kas Bebas
-$20.6M
Utang Bersih
$14.9M
Kas
$12.4M
Total Utang
$27.2M
Per tanggal Des 31, 2025
Як CRBU виглядає на тлі конкурентів у Biotechnology?
Група порівняння: Micro-cap Biotechnology (All) · 528 компаній
Оцінка CRBU vs аналоги Biotechnology
P/E
—
▼
0%
di bawah
rekan
(18,8)
vs Rekan
vs Industri
Undervalued
P/S
16,0
▲
24%
di atas
rekan
(12,9)
vs Rekan
vs Industri
Lebih mahal
P/B
0,6
▼
77%
di bawah
rekan
(2,5)
vs Rekan
vs Industri
Undervalued
Дивідендна дохідність
—
▼
0%
di bawah
rekan
(0,0%)
vs Rekan
vs Industri
Yield rendah
Прибутковість CRBU vs аналоги Biotechnology
ROE
-80,8%
▼
20%
di bawah
rekan
(-67,3%)
vs Rekan
vs Industri
Di bawah rata-rata
Net margin
-1690,5%
▼
490%
di bawah
rekan
(-286,8%)
vs Rekan
vs Industri
Lemah
Валова маржа
—
▼
0%
di bawah
rekan
(78,6%)
vs Rekan
vs Industri
Sejajar
ROA
-62,7%
▼
34%
di bawah
rekan
(-46,7%)
vs Rekan
vs Industri
Lemah
Фінансове здоровʼя CRBU vs аналоги Biotechnology
D/E ratio
0,0
▼
0%
di bawah
rekan
(0,0)
vs Rekan
vs Industri
Utang rendah
Поточна ліквідність
5,5
▲
25%
di atas
rekan
(4,4)
vs Rekan
vs Industri
Di bawah rata-rata
Beta
2,7
▲
177%
di atas
rekan
(1,0)
vs Rekan
vs Industri
Lebih volatil
Радар фундаменталів CRBU
CRBU
Median rekan
Industri
CRBU прибутковість vs борг
Розмір бульбашки = капіталізація · X = чиста маржа · Y = D/E ratio
CRBU vs аналоги: ключові метрики
Aktivitas Orang Dalam
NeutralPembelian
0
Penjualan
0
KELLY TIMOTHY P
Chief Technology Officer · Feb 25
6228 shs
MCCLUNG BARBARA G
Officer · Feb 24
6938 shs
KELLY TIMOTHY P
Chief Technology Officer · Feb 24
3147 shs
KHAN RUHI AHMAD
Officer · Feb 24
6938 shs
ALBERTSON TINA M.
Officer · Feb 24
1066 shs
MCCLUNG BARBARA G
Officer · Feb 20
45000 shs
HAURWITZ RACHEL E. PH.D.
Chief Executive Officer · Feb 20
151700 shs
KELLY TIMOTHY P
Chief Technology Officer · Feb 20
45000 shs
RYALI SRIRAM
Chief Financial Officer · Feb 20
55000 shs
KHAN RUHI AHMAD
Officer · Feb 20
45000 shs
Terakhir 90 hari
Pemegang Terbesar
Top 5: 15,81%Pfizer Inc
4,85%
$8.3M
Vanguard Group Inc
4,45%
$7.7M
Kynam Capital Management, LP
2,59%
$4.5M
Blackrock Inc.
2,22%
$3.8M
Renaissance Technologies, L…
1,70%
$2.9M
Per tanggal Des 31, 2025
Berita Terbaru
Belum ada berita terkait